Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 30. November 2025
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2141  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 42811  
   
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysis.
Mult Scler Relat Disord
Schoof LG, Rød BE, El Mahdaoui S, Michelsen JS, Høgestøl EA, Myhr KM, Rise HH, Su Z, Eriksson F, Friede T, Lundell H, Sellebjerg F, Sidaros K, Siebner HR, Wiggermann V, Jasperse B, Lissenberg-Witte B, van Oosten BW, Schoonheim MM, Edan G, Gaubert M, Le Page E, Kerbrat A, Michel L, Strijbis EMM, Torkildsen Ø, Christensen JR.
PMID: 41317517 [PubMed - as supplied by publisher]


Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing-remitting multiple sclerosis: a multi-center validation study.
J Neurol
Wang Z, Li S, Liu J, Li Y, Tang M, Wang J, Ren W, Guo J, Shao Z, Jiang J, Jia F, Li H, Xu X, Liu G, Jiang Y, Ding Y, Ai K, Zhang J.
PMID: 41317205 [PubMed - indexed for MEDLINE]


Prevalence and synergistic impact of neuropathic pain and fibromyalgia on disability and quality of life in multiple sclerosis: a cross-sectional study.
Rheumatol Int
Agirman M, Canturk IA, Usen A.
PMID: 41317173 [PubMed - indexed for MEDLINE]


A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis.
BMC Neurol
Zhang Y, Liu H, Li Z, Zhou M, Cai M, Liu L, Lin A, Xu Y.
PMID: 41316046 [PubMed - indexed for MEDLINE]


Epstein-Barr virus and multiple sclerosis: A mechanism comes into focus.
Mult Scler Relat Disord
Lindsey JW.
PMID: 41313861 [PubMed - as supplied by publisher]


NLRC5-Mediated Epigenetic and Proteomic Regulation of Microglial Panoptosis Drives Neuroinflammation in Multiple Sclerosis.
Mol Neurobiol
Yan W, Jianhong W, Ping G.
PMID: 41313522 [PubMed - indexed for MEDLINE]


Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis Patients.
Eur J Neurol
Poretto V, Endrizzi W, Betti M, Bovo S, Bellinvia A, Ragni F, Lapucci C, Moroni M, Marangoni S, Portaccio E, Longo C, Gios L, Chierici M, Jurman G, Giometto B, Inglese M, Osmani V, Marenco M, Uccelli A, Amato MP.
PMID: 41312659 [PubMed - indexed for MEDLINE]


Fear of disease progression and relapse in multiple sclerosis: a systematic scoping review.
Front Psychiatry
Mallahzadeh A, Fereydoonnezhad T, Gauthier LV, Farjoud Kouhanjani M, Hosseinizadeh S, Khatibi A.
PMID: 41311821 [PubMed]


Comparative Efficacy of Ublitixumab Versus Natalizumab in the Treatment of Relapsing and Remitting Multiple Sclerosis.
Cureus
Chitturi SV, Amith Priyansu J, Sadhu A, Ramisetty H, Pallapothu MR, Kogantii D.
PMID: 41311752 [PubMed]


Effectiveness of Dry Cupping Therapy on Fatigue and Quality of Life of Women with Multiple Sclerosis: Randomized Clinical Trial.
Iran J Nurs Midwifery Res
Sohrabi F, Tirgari B, Forouzi MA, Roy SC, Tajadini H, Jahani Y, Seifaddini R.
PMID: 41311603 [PubMed]


Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy.
J Neurol
Kleinschnitz C, Skripuletz T, Pfeuffer S, Pawlitzki M, Rieckmann P, Penner IK, Knaup J, Wagner T, Hübschen M, Hellwig K, Pul R.
PMID: 41310199 [PubMed - indexed for MEDLINE]


Towards primary prevention of multiple sclerosis.
Nat Rev Neurol
Dobson R, Kreft KL, Jacobs BM, Brown JWL, Thomson A, Nicholas R, Walton C, Narendran P, UK MS Prevention Taskforce.
PMID: 41310024 [PubMed - as supplied by publisher]


Understanding glial cells: Implications for multiple sclerosis pathogenesis and therapeutics.
Ageing Res Rev
Lalmani YS, Deshmukh R.
PMID: 41308840 [PubMed - as supplied by publisher]


Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study.
J Neuroimmunol
Miyazaki Y, Yokote H, Fujimori J, Sakurai K, Hagiwara A, Fujino S, Fukami T, Takahashi E, Miyagishi M, Uwatoko M, Sugimura Y, Amino I, Akimoto S, Izumi K, Minato K, Minami N, Niino M.
PMID: 41308241 [PubMed - as supplied by publisher]


Mortality trends in multiple sclerosis and cardiovascular disease in adults in the United States: A 25-year mortality perspective.
Mult Scler Relat Disord
Hemida MF, Ibrahim AA, Shahriar Z, Khalid M, Zeeshan N, Qaisi W, Hussein M, Sarfraz MR, Rabie OM, Saghir M, Saghir E, Jalal AA, Alagamy M, Tabasum P, Ahmed R.
PMID: 41308235 [PubMed - as supplied by publisher]


Functional connectivity changes are associated with disability progression in multiple sclerosis: a longitudinal fMRI study.
J Neurol
Piervincenzi C, Ojha A, Tommasin S, Satriano F, Petsas N, Gallo A, d'Ambrosio A, De Stefano N, Cortese R, Valsasina P, Tedone N, Pozzilli C, Rocca MA, Filippi M, Pantano P, INNI Network.
PMID: 41307737 [PubMed - indexed for MEDLINE]


Gait Kinematics Assessed by Vicon(®) and Quality of Life Correlations in Multiple Sclerosis Patients: A Cross-Sectional Study.
Sensors (Basel)
Micolas O, Gil-Gregorio M, Uría-Oruezábal AM, López-González R, González-de-la-Flor Á, Giménez MJ, García-Arrabé M, Estrada-Barranco C.
PMID: 41305115 [PubMed - indexed for MEDLINE]


The Age-Related Efficacy of Dimethyl Fumarate in Naive Versus Switcher Multiple Sclerosis Patients: A Multicenter Population-Based Study.
Pharmaceuticals (Basel)
De Masi R, Orlando S, Greco A, Costa MC.
PMID: 41304974 [PubMed]


Disease-Modifying Treatment Options in Very Early Onset Multiple Sclerosis-What Choices Are There for Onset Under 5 Years of Age? A Systematic Review.
J Clin Med
Craiu D, Dica AD, Pomeran C, Pescaru G, Menascu S, Simu M.
PMID: 41303170 [PubMed]


Evolving the Diagnosis of Multiple Sclerosis: A New Landscape in Light of the 2024 McDonald Criteria.
Biomedicines
Samara A, Ontaneda D.
PMID: 41301685 [PubMed]


   
   Artikel 1 - 20 / 42811    Seite 1 von 2141  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1